Exclusive

Publication

Byline

Location

Clinical Trial: Ultra-early Identification of Futile Recanalization After Reperfusion Therapy in Acute Ischemic Stroke Based on Cerebral Autoregulation Monitoring

U.S., Aug. 6 -- ClinicalTrials.gov registry received information related to the study (NCT07747701) titled 'Ultra-early Identification of Futile Recanalization After Reperfusion Therapy in Acute Ische... Read More


Clinical Trial: Effect of Titanium-Prepared Platelet-Rich Fibrin and Low-Level Laser Therapy on Postoperative Morbidity After Mandibular Third Molar Surgery

U.S., Aug. 6 -- ClinicalTrials.gov registry received information related to the study (NCT07748585) titled 'Effect of Titanium-Prepared Platelet-Rich Fibrin and Low-Level Laser Therapy on Postoperativ... Read More


Singapore Clinical Trial: ROSETTA Lung-201: A Randomized, Multicenter, Open-label Phase 3 Study of Pumitamig Monotherapy Compared to Durvalumab in Participants with Unresectable Stage III NSCLC Without Progression After Platinum-based Concurrent Chemoradiation Therapy.

Singapore, Aug. 6 -- The Health Sciences Authority received information related to the study titled 'ROSETTA Lung-201: A Randomized, Multicenter, Open-label Phase 3 Study of Pumitamig Monotherapy Comp... Read More


Clinical Trial: DNA Methylation in PMR

U.S., Aug. 6 -- ClinicalTrials.gov registry received information related to the study (NCT07748195) titled 'DNA Methylation in PMR' on April 29. Brief Summary: Polymyalgia Rheumatica (PMR) is treated... Read More


Singapore Clinical Trial: A Phase 2, Randomized, Open-Label Study of VVD-133214 in Combination with Pembrolizumab compared with Pembrolizumab monotherapy in participants with advanced colorectal adenocarcinoma (CRC) harboring microsatellite instability (MSI) and/or deficient mismatch repair (DMMR)

Singapore, Aug. 6 -- The Health Sciences Authority received information related to the study titled 'A Phase 2, Randomized, Open-Label Study of VVD-133214 in Combination with Pembrolizumab compared wi... Read More


Singapore Clinical Trial: A Phase 3, Randomized, Double-blind, Placebo-controlled Study of Investigator Choice of Chemotherapy (modified FOLFIRINOX or Gemcitabine plus Nab-paclitaxel) with or without Zoldonrasib (RMC 9805) as First-line Treatment in Patients with Metastatic KRAS G12D-mutated Pancreatic Adenocarcinoma (RASolute 305)

Singapore, Aug. 6 -- The Health Sciences Authority received information related to the study titled 'A Phase 3, Randomized, Double-blind, Placebo-controlled Study of Investigator Choice of Chemotherap... Read More


Clinical Trial: Talking Circle for Native American Youth Living Well (AYoLi)

U.S., Aug. 6 -- ClinicalTrials.gov registry received information related to the study (NCT07746375) titled 'Talking Circle for Native American Youth Living Well (AYoLi)' on July 29. Brief Summary: Th... Read More


Clinical Trial: Effects of Exercise Prior to Radical Prostatectomy

U.S., Aug. 6 -- ClinicalTrials.gov registry received information related to the study (NCT07746414) titled 'Effects of Exercise Prior to Radical Prostatectomy' on July 29. Brief Summary: This pilot s... Read More


Singapore Clinical Trial: A Phase 1, Investigator- and Participant-Blinded, Placebo-Controlled, Randomized, Multiple-Dose Study to Evaluate the Gastric Emptying Delay, Pharmacokinetics, Safety, and Tolerability of Eloralintide in Participants with Obesity or Overweight

Singapore, Aug. 6 -- The Health Sciences Authority received information related to the study titled 'A Phase 1, Investigator- and Participant-Blinded, Placebo-Controlled, Randomized, Multiple-Dose Stu... Read More


Clinical Trial: Smart Inhaler and Remote Asthma Management in Adolescents With Intellectual and Developmental Disabilities

U.S., Aug. 6 -- ClinicalTrials.gov registry received information related to the study (NCT07746921) titled 'Smart Inhaler and Remote Asthma Management in Adolescents With Intellectual and Developmenta... Read More